Eiko LifeSciences Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 43.76 million compared to INR 55.8 million a year ago. Revenue was INR 45.62 million compared to INR 57.28 million a year ago. Net income was INR 2.54 million compared to net loss of INR 0.612 million a year ago. Basic earnings per share from continuing operations was INR 0.31 compared to basic loss per share from continuing operations of INR 0.07 a year ago. Diluted earnings per share from continuing operations was INR 0.31 compared to diluted loss per share from continuing operations of INR 0.07 a year ago.
For the nine months, sales was INR 117.27 million compared to INR 201.2 million a year ago. Revenue was INR 123.74 million compared to INR 205.88 million a year ago. Net income was INR 4.86 million compared to INR 5.59 million a year ago. Basic earnings per share from continuing operations was INR 0.58 compared to INR 0.73 a year ago. Diluted earnings per share from continuing operations was INR 0.58 compared to INR 0.73 a year ago.